MLTX - CIK 0001821586
MoonLake Immunotherapeutics has filed 296 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (67 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| Insider trade | 4 | 2026-05-13 | 2026-05-11 |
| Quarterly report | 10-Q | 2026-05-11 | 2026-03-31 |
| Major company event | 8-K | 2026-05-11 | 2026-05-10 |
| Annual report to shareholders | ARS | 2026-04-21 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-21 | - |
| Proxy statement | DEF 14A | 2026-04-21 | 2026-06-04 |
| Insider trade | 4 | 2026-04-16 | 2026-04-14 |
| Insider trade | 4 | 2026-04-14 | 2026-04-10 |
| Insider sale notice | 144 | 2026-04-10 | - |
| Insider trade | 4 | 2026-04-10 | 2026-04-09 |
| Insider sale notice | 144 | 2026-04-09 | - |
| Insider trade | 4 | 2026-04-02 | 2026-03-31 |
| SCHEDULE 13D/A | - | 2026-04-02 | - |
| Insider sale notice | 144 | 2026-03-31 | - |
| Annual report | 10-K | 2026-02-25 | 2025-12-31 |
| Major company event | 8-K | 2026-02-23 | 2026-02-18 |
| SCHEDULE 13G | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Major company event | 8-K | 2026-01-08 | 2026-01-08 |
| Insider trade | 4 | 2025-12-22 | 2025-12-19 |
| Insider trade | 4 | 2025-12-22 | 2025-12-19 |
| Insider trade | 4 | 2025-12-22 | 2025-12-19 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider trade | 4 | 2025-12-10 | 2025-12-08 |
| Insider sale notice | 144 | 2025-12-08 | - |
| Insider sale notice | 144 | 2025-12-08 | - |
| SCHEDULE 13G/A | - | 2025-11-14 | - |
| SCHEDULE 13G | - | 2025-11-12 | - |
| SCHEDULE 13D/A | - | 2025-11-10 | - |
| Quarterly report | 10-Q | 2025-11-05 | 2025-09-30 |
| Major company event | 8-K | 2025-11-05 | 2025-11-05 |
| Major company event | 8-K | 2025-11-05 | 2025-11-05 |
| Prospectus supplement | 424B5 | 2025-11-05 | - |
| SCHEDULE 13G/A | - | 2025-11-05 | - |
| Insider trade | 4 | 2025-10-09 | 2025-10-08 |
| SCHEDULE 13G/A | - | 2025-10-01 | - |
| Insider trade | 4 | 2025-10-01 | 2025-09-29 |
| Major company event | 8-K | 2025-09-29 | 2025-09-29 |
| Insider trade | 4 | 2025-09-04 | 2025-09-02 |
| SCHEDULE 13G | - | 2025-08-14 | - |
| SCHEDULE 13G/A | - | 2025-08-06 | - |
| Quarterly report | 10-Q | 2025-08-05 | 2025-06-30 |
| Major company event | 8-K | 2025-08-05 | 2025-08-05 |
| Insider trade | 4 | 2025-07-07 | 2025-07-03 |
| Insider sale notice | 144 | 2025-07-03 | - |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |